Marker Therapeutics, Inc. (MRKR)

2.00 -0.07 (-3.38%) USD  |  NASDAQ  |  Jan 09, 16:00
1.99 -0.01 (-0.50%) After-Hours: 07:24
More

Marker Therapeutics Operating Income (TTM)

Operating Income (TTM) Chart

View Operating Income (TTM) for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (TTM) Range, Past 5 Years

View Operating Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (TTM) Benchmarks

View Operating Income (TTM) Benchmarks
Start Trial
ADMA Biologics, Inc. Upgrade
Viridian Therapeutics, Inc. Upgrade
Neurocrine Biosciences, Inc. Upgrade
Kiniksa Pharmaceuticals International Plc Upgrade
AIM ImmunoTech, Inc. Upgrade